Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2018 (2018), Article ID 7919165, 7 pages
https://doi.org/10.1155/2018/7919165
Research Article

Correlation of Serum Uric Acid Levels with Nonculprit Plaque Instability in Patients with Acute Coronary Syndromes: A 3-Vessel Optical Coherence Tomography Study

Department of Cardiology, Key Laboratories of Education Ministry for Myocardial Ischemia Mechanism and Treatment, 2nd Affiliated Hospital of Harbin Medical University, Harbin 150086, China

Correspondence should be addressed to Bo Yu; moc.361@rdobuy

Received 23 August 2017; Revised 10 December 2017; Accepted 18 December 2017; Published 7 February 2018

Academic Editor: Cheng-I Cheng

Copyright © 2018 Donghui Zhang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. F. Culleton, M. G. Larson, W. B. Kannel, and D. Levy, “Serum uric acid and risk for cardiovascular disease and death: the Framingham heart study,” Annals of Internal Medicine, vol. 131, no. 1, pp. 7–13, 1999. View at Publisher · View at Google Scholar · View at Scopus
  2. G. Ndrepepa, S. Braun, H.-U. Haase et al., “Prognostic value of uric acid in patients with acute coronary syndromes,” American Journal of Cardiology, vol. 109, no. 9, pp. 1260–1265, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. M. N. Diaz, B. Frei, J. A. Vita, and J. F. Keaney Jr., “Antioxidants and atherosclerotic heart disease,” The New England Journal of Medicine, vol. 337, no. 6, pp. 408–416, 1997. View at Publisher · View at Google Scholar · View at Scopus
  4. F. A. Mahomed, “On chronic bright's disease, and its essential symptoms,” The Lancet, vol. 113, no. 2899, pp. 399–401, 1879. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Haig, “On uric acid and arterial tension,” British Medical Journal, vol. 1, no. 1467, pp. 288–291, 1889. View at Publisher · View at Google Scholar · View at Scopus
  6. Y. Saito, T. Nakayama, K. Sugimoto, Y. Fujimoto, and Y. Kobayashi, “Relation of lipid content of coronary plaque to level of serum uric acid,” American Journal of Cardiology, vol. 116, no. 9, pp. 1346–1350, 2015. View at Publisher · View at Google Scholar · View at Scopus
  7. K. Ando, H. Takahashi, T. Watanabe et al., “Impact of serum uric acid levels on coronary plaque stability evaluated using integrated backscatter intravascular ultrasound in patients with coronary artery disease,” Journal of Atherosclerosis and Thrombosis, vol. 23, no. 8, pp. 932–939, 2016. View at Publisher · View at Google Scholar · View at Scopus
  8. E. B. Kaya, H. Yorgun, U. Canpolat et al., “Serum uric acid levels predict the severity and morphology of coronary atherosclerosis detected by multidetector computed tomography,” Atherosclerosis, vol. 213, no. 1, pp. 178–183, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. L. Di Vito, J. H. Yoon, K. Kato et al., “Comprehensive overview of definitions for optical coherence tomography-based plaque and stent analyses,” Coronary Artery Disease, vol. 25, no. 2, pp. 172–185, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. F. Prati, E. Regar, G. S. Mintz et al., “Expert review document on methodology, terminology, and clinical applications of optical coherence tomography: Physical principles, methodology of image acquisition, and clinical application for assessment of coronary arteries and atherosclerosis,” European Heart Journal, vol. 31, no. 4, pp. 401–415, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. K. Kato, T. Yonetsu, S.-J. Kim et al., “Nonculprit plaques in patients with acute coronary syndromes have more vulnerable features compared with those with non-acute coronary syndromes a 3-vessel optical coherence tomography study,” Circulation: Cardiovascular Imaging, vol. 5, no. 4, pp. 433–440, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. H. Yabushita, B. E. Bouma, S. L. Houser et al., “Characterization of human atherosclerosis by optical coherence tomography,” Circulation, vol. 106, no. 13, pp. 1640–1645, 2002. View at Publisher · View at Google Scholar · View at Scopus
  13. I.-K. Jang, G. J. Tearney, B. MacNeill et al., “In vivo characterization of coronary atherosclerotic plaque by use of optical coherence tomography,” Circulation, vol. 111, no. 12, pp. 1551–1555, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. T. Kubo, T. Imanishi, S. Takarada et al., “Assessment of culprit lesion morphology in acute myocardial infarction: ability of optical coherence tomography compared with intravascular ultrasound and coronary angioscopy,” JACC: Journal of the American College of Cardiology, vol. 50, no. 10, pp. 933–939, 2007. View at Google Scholar
  15. K. Fujii, D. Kawasaki, M. Masutani et al., “OCT Assessment of Thin-Cap Fibroatheroma Distribution in Native Coronary Arteries,” JACC: Cardiovascular Imaging, vol. 3, no. 2, pp. 168–175, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. T. Lee, T. Yonetsu, K. Koura et al., “Impact of coronary plaque morphology assessed by optical coherence tomography on cardiac troponin elevation in patients with elective stent implantation,” Circulation: Cardiovascular Interventions, vol. 4, no. 4, pp. 378–386, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. B. D. MacNeill, I.-K. Jang, B. E. Bouma et al., “Focal and multi-focal plaque macrophage distributions in patients with acute and stable presentations of coronary artery disease,” Journal of the American College of Cardiology, vol. 44, no. 5, pp. 972–979, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. A. S. Bharadwaj, Y. Vengrenyuk, T. Yoshimura et al., “Multimodality Intravascular Imaging to Evaluate Sex Differences in Plaque Morphology in Stable CAD,” JACC: Cardiovascular Imaging, vol. 9, no. 4, pp. 400–407, 2016. View at Publisher · View at Google Scholar · View at Scopus
  19. G. J. Tearney, E. Regar, T. Akasaka et al., “Consensus standards for acquisition, measurement, and reporting of intravascular optical coherence tomography studies: a report from the International Working Group for Intravascular Optical Coherence Tomography Standardization and Validation,” Journal of the American College of Cardiology, vol. 59, no. 12, pp. 1058–1072, 2012. View at Google Scholar
  20. H. Ikenaga, M. Ishihara, I. Inoue et al., “Longitudinal extent of lipid pool assessed by optical coherence tomography predicts microvascular no-reflow after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction,” Journal of Cardiology, vol. 62, no. 2, pp. 71–76, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. M. M. Gertler, S. M. Garn, and S. A. Levine, “Serum uric acid in relation to age and physique in health and in coronary heart disease,” Annals of Internal Medicine, vol. 34, no. 6, pp. 1421–1431, 1951. View at Publisher · View at Google Scholar · View at Scopus
  22. O. Sinan Deveci, G. Kabakci, S. Okutucu et al., “The association between serum uric acid level and coronary artery disease,” International Journal of Clinical Practice, vol. 64, no. 7, pp. 900–907, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. M. J. Bos, P. J. Koudstaal, A. Hofman, J. C. M. Witteman, and M. M. B. Breteler, “Uric acid is a risk factor for myocardial infarction and stroke: The Rotterdam Study,” Stroke, vol. 37, no. 6, pp. 1503–1507, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. I. Holme, A. H. Aastveit, N. Hammar, I. Jungner, and G. Walldius, “Uric acid and risk of myocardial infarction, stroke and congestive heart failure in 417 734 men and women in the Apolipoprotein MOrtality RISk study (AMORIS),” Journal of Internal Medicine, vol. 266, no. 6, pp. 558–570, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. G. Zhao, L. Huang, M. Song, and Y. Song, “Baseline serum uric acid level as a predictor of cardiovascular disease related mortality and all-cause mortality: A meta-analysis of prospective studies,” Atherosclerosis, vol. 231, no. 1, pp. 61–68, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. F. Braga, S. Pasqualetti, S. Ferraro, and M. Panteghini, “Hyperuricemia as risk factor for coronary heart disease incidence and mortality in the general population: a systematic review and meta-analysis,” Clinical Chemistry and Laboratory Medicine, vol. 54, no. 1, pp. 7–15, 2016. View at Publisher · View at Google Scholar · View at Scopus
  27. C. Ruggiero, A. Cherubini, A. Ble et al., “Uric acid and inflammatory markers,” European Heart Journal, vol. 27, no. 10, pp. 1174–1181, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Duran, N. Kalay, M. Akpek et al., “High levels of serum uric acid predict severity of coronary artery disease in patients with acute coronary syndrome,” Angiology, vol. 63, no. 6, pp. 448–452, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. J.-W. Zhang, L.-J. He, S.-J. Cao, Q. Yang, S.-W. Yang, and Y.-J. Zhou, “Association of serum uric acid and coronary artery disease in premenopausal women,” PLoS ONE, vol. 9, no. 9, Article ID e106130, 2014. View at Publisher · View at Google Scholar · View at Scopus
  30. H. J. Ward, “Uric acid as an independent risk factor in the treatment of hypertension,” The Lancet, vol. 352, no. 9129, pp. 670-671, 1998. View at Publisher · View at Google Scholar · View at Scopus
  31. L. V. Franse, M. Pahor, M. D. Bari et al., “Serum uric acid, diuretic treatment and risk of cardiovascular events in the Systolic Hypertension in the Elderly Program (SHEP),” Journal of Hypertension, vol. 18, no. 8, pp. 1149–1154, 2000. View at Publisher · View at Google Scholar · View at Scopus
  32. M. G. Kaya, H. Uyarel, M. Akpek et al., “Prognostic value of uric acid in patients with ST-elevated myocardial infarction undergoing primary coronary intervention,” American Journal of Cardiology, vol. 109, no. 4, pp. 486–491, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. T. Nozue, S. Yamamoto, S. Tohyama et al., “Correlations between serum uric acid and coronary atherosclerosis before and during statin therapy,” Coronary Artery Disease, vol. 25, no. 4, pp. 343–348, 2014. View at Publisher · View at Google Scholar · View at Scopus
  34. M. Akpek, M. G. Kaya, H. Uyarel et al., “The association of serum uric acid levels on coronary flow in patients with STEMI undergoing primary PCI,” Atherosclerosis, vol. 219, no. 1, pp. 334–341, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. I. Morishima, T. Sone, K. Okumura et al., “Angiographic no-reflow phenomenon as a predictor of adverse long-term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction,” Journal of the American College of Cardiology, vol. 36, no. 4, pp. 1202–1209, 2000. View at Publisher · View at Google Scholar · View at Scopus
  36. Y. J. Hong, M. H. Jeong, Y. H. Choi et al., “Impact of plaque components on no-reflow phenomenon after stent deployment in patients with acute coronary syndrome: A virtual histology-intravascular ultrasound analysis,” European Heart Journal, vol. 32, no. 16, pp. 2059–2066, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. H. Amano, K. Wagatsuma, J. Yamazaki, and T. Ikeda, “Virtual histology intravascular ultrasound analysis of attenuated plaque and ulcerated plaque detected by gray scale intravascular ultrasound and the relation between the plaque composition and slow flow/no reflow phenomenon during percutaneous coronary intervention,” Journal of Interventional Cardiology, vol. 26, no. 3, pp. 295–301, 2013. View at Publisher · View at Google Scholar · View at Scopus